Napoleon Monroe, the sole inventor of the mMed medication-telemanagement patents, has been involved in the successful commercialisation of patents for decades. He spent more than 20 years at Survival Technology (now part of Pfizer), where he built up and managed its IP portfolio. There, he invented three medical devices that were patented and commercialised – two for autoinjectors and one for a transtelephonic peak-flow monitoring device. Mr Monroe also led teams that invented, prototyped, tested, commercialised and scaled up emergency pharmaceutical delivery systems, such as the original EpiPen, for treatment of anaphylactic shock, and the Antidote Treatment Nerve Agent AutoInjector delivery system, which still protects US and allied military and civilian personnel.

More contributions